Grant Awarded for Device to Detect Newborn Heart Problems

LA BioMed Partnering with QT Medical to Identify Infants at Risk of Long QT Syndrome

LOS ANGELES – (Oct. 28, 2014) –Each year, some 2,000 babies are born in the U.S. with a genetic heart condition, known as long QT syndrome. If not diagnosed in time, babies with long QT syndrome can die from a sudden arrhythmia, or irregular heartbeat.

Advancing Innovation Gala to Honor Leaders of Companies Built on LA BioMed Research

Dr. John Michael Criley receiving an award

Event also Will Recognize Dr. John Michael Criley for His Leadership

LOS ANGELES – (September 24, 2014) – On Oct. 18 at its Advancing Innovation Gala, Los Angeles Biomedical Research Institute (LA BioMed) will recognize three champions of innovation who are leading companies built on research conducted at LA BioMed: Timothy Cooke, PhD., Keith Leonard and Yutaka Niihara, MD.

The Advancing Innovation Gala also will honor John Michael Criley, MD, an LA BioMed Legend and researcher, who pioneered the modern U.S. paramedic model of providing emergency care.

Universal Screening for MRSA May be Too Costly

Researchers Identify Why Hospitals May Not “Get in the Ring” to Fight “Superbug”

PHILADELPHIA – (Oct. 8, 2014) – Numerous experts and policy makers have called for hospitals to screen patients for methicillin-resistant Staphylococcus aureus (MRSA) infections and isolate anyone testing positive to prevent the spread of these so-called “Superbugs” in healthcare settings. Several states have enacted laws requiring patients be screened for MRSA upon admission.

Marijuana Use Associated with Lower Death Rates In Patients with Traumatic Brain Injuries

LA BioMed Researchers Surveyed Emergency Patients Tested for THC Levels

LOS ANGELES – (Oct. 1, 2014) – Surveying patients with traumatic brain injury, a group of Los Angeles Biomedical Research Institute (LA BioMed) researchers reported today that they found those who tested positive for THC, the active ingredient in marijuana, were more likely to survive than those who tested negative for the illicit substance.

Study Holds Hope of a Treatment For Deadly Genetic Disease, MPS IIIB

Researchers Find Method for Replacing Missing Enzyme in the Brain.

LOS ANGELES – (Oct. 1, 2014) – MPS IIIB is a devastating and currently untreatable disease that causes progressive damage to the brain, leading to profound intellectual disability, dementia and death — often before reaching adulthood.

Study Finds Gallbladder Surgery Can Wait.

Patients benefit from minimally invasive procedures.

LOS ANGELES – (September 23, 2014) –

Laparoscopic cholecystectomy, a minimally invasive procedure to remove the gallbladder, is one of the most common abdominal surgeries in the U.S. Yet medical centers around the country vary in their approaches to the procedure with some moving patients quickly into surgery while others wait.

Susan D. Rubin Joins LA BioMed Leadership Team

Susan Rubin

New Research Executive Brings Wealth of Experience to Institute

LOS ANGELES – (August 18, 2014) – Bringing a wealth of experience in research administration, Susan D. Rubin recently joined Los Angeles Biomedical Research Institute (LA BioMed) in a newly created role of chief operating officer and general counsel.

LA BioMed Names Six New Board Members

LOS ANGELES – (August 15, 2014) – Los Angeles Biomedical Research Institute (LA BioMed) recently named six new members to its Board of Directors, expanding the board’s expertise in the law, scientific research, engineering, development, public affairs and more.

David B. Duthu, Dr. David Heber, Joan Hood Jones, Anne-Merelie Murrell, Barnet Resnick and Dan Rosenfeld have joined the board of LA BioMed, one of the nation’s leading nonprofit independent research institutes.

The Obesity Paradox

Kamyar Kalantar-Zadeh

Kamyar Kalantar-Zadeh, the world’s foremost expert on end-stage kidney disease, has followed his research to the controversial proposition that obesity might be a patient’s best friend in the hour of greatest need.

Recent findings by Kalantar-Zadeh and some of his colleagues have landed him square in the middle of an “obesity paradox,” which is the subject of sometimes heated debate among physicians, researchers and public health officials.

How Ayahuasca Can Revolutionize Psychotherapy

Article from

A look at the psychoactive brew that brings users a spiritual payoff for their “work”
In a greenhouse at the University of Minnesota, Dennis McKenna walks past the cacao (chocolate) and the Punica (pomegranate), and strides straight to the back corner, where the vines of the plant Banisteriopsis have twisted around each other — and nearby electrical cords — to reach the room’s rafters.